Waitzberg Dan L, Saito Hideaki, Plank Lindsay D, Jamieson Glyn G, Jagannath Palepu, Hwang Tsann-Long, Mijares Juan M, Bihari David
Department of Gastroenterology, LIM 35, University of São Paulo Medical School, Sao Paulo, Brazil, and Lilavati Hospital, Mumbai, India.
World J Surg. 2006 Aug;30(8):1592-604. doi: 10.1007/s00268-005-0657-x.
The objective was to examine the relationship between pre-, peri-, and postoperative specialized nutritional support with immune-modulating nutrients and postoperative morbidity in patients undergoing elective surgery.
Studies were identified by searching MEDLINE, review article bibliographies, and abstracts and proceedings of scientific meetings. All randomized clinical trials in which patients were supplemented by the IMPACT formula before and/or after elective surgery and the clinical outcomes reported were included in the meta-analysis. Seventeen studies (n=2,305), 14 published (n=2,102), and 3 unpublished (n=203), fulfilled the inclusion criteria. Ten studies (n=1,392) examined the efficacy of pre- or perioperative IMPACT supplementation in patients undergoing elective surgery, whereas 7 (n=913) assessed postoperative efficacy. Fourteen of the studies (n=2,083) involved gastrointestinal (GI) surgical patients. Postoperative complications, mortality, and length of stay in hospital (LOS) were major outcomes of interest.
IMPACT supplementation, in general, was associated with significant (39%-61%) reductions in postoperative infectious complications and a significant decrease in LOS in hospital by an average of 2 days. The greatest improvement in postoperative outcomes was observed in patients receiving specialized nutrition support as part of their preoperative treatment. In GI surgical patients, anastomotic leaks were 46% less prevalent when IMPACT supplementation was part of the preoperative treatment.
This study identifies a dosage (0.5-1 l/day) and duration (supplementation for 5-7 days before surgery) of IMPACT that contributes to improved outcomes of morbidity in elective surgery patients, particularly those undergoing GI surgical procedures. The cost effectiveness of such practice is supported by recent health economic analysis. Findings suggest preoperative IMPACT use for the prophylaxis of postoperative complications in elective surgical patients.
本研究旨在探讨择期手术患者术前、术中和术后给予含免疫调节营养素的特殊营养支持与术后发病率之间的关系。
通过检索MEDLINE、综述文章参考文献以及科学会议的摘要和论文集来确定研究。所有在择期手术前和/或后使用IMPACT配方进行补充并报告临床结果的随机临床试验均纳入荟萃分析。17项研究(n = 2305),其中14项已发表(n = 2102),3项未发表(n = 203),符合纳入标准。10项研究(n = 1392)探讨了择期手术患者术前或围手术期使用IMPACT补充剂的疗效,而7项研究(n = 913)评估了术后疗效。其中14项研究(n = 2083)涉及胃肠道(GI)手术患者。术后并发症、死亡率和住院时间(LOS)是主要关注的结局指标。
总体而言,使用IMPACT补充剂可使术后感染并发症显著降低(39%-61%),住院时间平均显著缩短2天。作为术前治疗一部分接受特殊营养支持的患者术后结局改善最为明显。在胃肠道手术患者中,术前使用IMPACT补充剂时吻合口漏的发生率降低46%。
本研究确定了IMPACT的剂量(0.5-1升/天)和持续时间(术前补充5-7天),有助于改善择期手术患者的发病结局,尤其是接受胃肠道手术的患者。近期的卫生经济分析支持了这种做法的成本效益。研究结果表明,术前使用IMPACT可预防择期手术患者的术后并发症。